Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Rituximab in Membranous Nephropathy
RITERM study group
Nephrology and Hypertension
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rituximab in Membranous Nephropathy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Membranous Glomerulonephritis
100%
Rituximab
85%
Phospholipase A2 Receptors
32%
Safety
22%
Nephrotic Syndrome
22%
Proteinuria
18%
B-Lymphocytes
15%
Randomized Controlled Trials
13%
Antigens
12%
Kidney
10%
Therapeutics
6%